Novago Therapeutics

Company developing human derived antibodies for cerebral stroke and spinal cord injury

placeWinterthur, Zurich, Switzerland calendar_todayFounded 2015 groups5 employees language novagotherapeutics.com

Social engagement

Social engagement: 1.8K social following, 1 post in the last 12 months — below the industry typical range.

Investor mix

5 investors on record; lead investors include Neurimmune, Pureos Bioventures.

Investor typeCountShare
Venture capital360%
Other / undisclosed240%

Hiring activity

Hires occasionally

1 role tracked across 1 of the last 12 months

26 Nov 2025 · Research Scientist – Biochemistry, molecular biology, cell biology · Zurich, Zurich

Based on job postings tracked across public sources.

Coming soon